BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 893240)

  • 1. Tobramycin-cephalothin treatment in leukaemic and neutropenic patients with severe infection.
    Papayannis AG; Thomopoulos D; Voulgaris E; Scliros P; Gardikas C
    J Antimicrob Chemother; 1977 Jul; 3(4):311-5. PubMed ID: 893240
    [No Abstract]   [Full Text] [Related]  

  • 2. Tobramycin and cephalothin for treatment of suspected sepsis in neutropenic children with cancer.
    Cohen JD; Miale TD
    J Infect Dis; 1976 Aug; 134 Suppl():S175-7. PubMed ID: 972278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients.
    Gaya H; Klastersky J; Schimpff SC; Fière D; Widmaier S; Nagel G
    Eur J Cancer (1965); 1975 Aug; 11suppl():5-8. PubMed ID: 767119
    [No Abstract]   [Full Text] [Related]  

  • 4. Tobramycin and cephalothin sodium in treatment of infected patients with acute leukemia.
    Vincent PC; Jennis F; Hilmer R; Fabre S
    J Infect Dis; 1976 Aug; 134 Suppl():S170-4. PubMed ID: 972277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients.
    Verhagen CS; de Pauw B; de Witte T; Janssen J; Williams K; de Mulder P; Bothof T
    Antimicrob Agents Chemother; 1987 Feb; 31(2):191-6. PubMed ID: 3551829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric treatment of fever in acute leukaemia with tobramycin-cephalothin, and the escape clause provision of corticosteroids.
    Hjorth M; Weinfeld A; Brorson JE
    Scand J Infect Dis; 1980; 12(2):139-48. PubMed ID: 7375825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of synergistic combinations of antibiotics in patients with haematological diseases.
    Klastersky J
    Clin Haematol; 1976 Jun; 5(2):361-77. PubMed ID: 780029
    [No Abstract]   [Full Text] [Related]  

  • 8. European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
    Croydon E; Weerts D
    Chemioterapia; 1987 Jun; 6(2 Suppl):405-7. PubMed ID: 3334585
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of a combination of cefotaxime, tobramycin and vancomycin as antibiotic therapy for neutropenia.
    Brunet F; Lanore JJ; Dhainaut JF; Dreyfus F; Huyghebaert MF; Varet B; Monsallier JF
    Drugs; 1988; 35 Suppl 2():195. PubMed ID: 3396480
    [No Abstract]   [Full Text] [Related]  

  • 10. Etiology of infections in neutropenic patients with acute leukemia. Results of two antibiotic combinations.
    Scaglione C; López H; Fernández A; Marcenac F; Garay G; Dupont J; Pavlovsky S
    Medicina (B Aires); 1981; 41 Suppl():29-34. PubMed ID: 6954341
    [No Abstract]   [Full Text] [Related]  

  • 11. [Infection in granulopenic patients. Early treatment with carbenicillin, cephalothin and tobramycin].
    Parlier Y; Najman A; Gorin NC; Petit JC; Tessier F
    Nouv Presse Med; 1980 Jan; 9(4):254-5. PubMed ID: 7383893
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of bacterial infections in severely neutropenic subjects.
    Vincent PC; Fabre S; Jennis F
    Med J Aust; 1977 Oct; 2(3 Pt 2 Suppl):30-3. PubMed ID: 244772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of febrile episodes in neutropenic patients.
    Melikian V; Falk R
    Scott Med J; 1976 Apr; 21(2):73-4. PubMed ID: 940999
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies.
    Lawson RD; Gentry LO; Bodey GP; Keating MJ; Smith TL
    Am J Med Sci; 1984; 287(1):16-23. PubMed ID: 6367466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empirical antibiotic therapy in febrile patients with neutropenia and malignant disease.
    Tattersall MH; Hutchinson RM; Gaya H; Spiers AS
    Eur J Cancer (1965); 1973 Jun; 9(6):417-23. PubMed ID: 4372049
    [No Abstract]   [Full Text] [Related]  

  • 16. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
    Feld R; Louie TJ; Mandell L; Bow EJ; Robson HG; Chow A; Belch A; Miedzinski L; Rachlis A; Pater J
    Arch Intern Med; 1985 Jun; 145(6):1083-8. PubMed ID: 3890789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease.
    Gaya H; Klastersky J; Schimpff SC; Tattersall MH
    Eur J Cancer (1965); 1975 Aug; 11suppl():1-4. PubMed ID: 767118
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
    Bezwoda WR; Derman DP; Perkins S; Cassel R
    J Antimicrob Chemother; 1985 Feb; 15(2):239-45. PubMed ID: 3884566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic combinations for infections in neutropenic patients. Evaluaton of carbenicillin plus either cephalothin or kanamycin.
    Middleman EL; Watanabe A; Kaizer H; Bodey GP
    Cancer; 1972 Aug; 30(2):573-9. PubMed ID: 5051680
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy of Klebsiella pneumoniae septicaemia in neutropenic rats.
    Magliulo E; Piantieri G; Cafarelli A; Cruciani M
    Pharmatherapeutica; 1982; 3(2):114-8. PubMed ID: 7048337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.